Please assess the completion status of the following clinical trial:

Trial Title: Prednisolone or Dexamethasone Combined With Chemotherapy in Treating Young Patients With Newly Diagnosed Lymphoblastic Lymphoma

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: None
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: None
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
DISEASE CHARACTERISTICS:~* Histologically or cytologically confirmed lymphoblastic lymphoma (LBL)~  * Stage I-IV disease~ * T-cell LBL, precursor B-cell LBL, or LBL with an unknown immunophenotype~PATIENT CHARACTERISTICS:~* Not pregnant or nursing~* Negative pregnancy test~* Fertile patients must use effective contraception during and for 3 months after completion of study treatment~* No known HIV or AIDS infection~* No severe immunodeficiency~* No other prior malignancy~* No prior disease that would preclude treatment with chemotherapy~PRIOR CONCURRENT THERAPY:~* More than 2 months since prior systemic corticosteroids for a duration of \> 8 days~* No prior chemotherapy~* No prior radiotherapy~* No prior organ transplant~* No trimethoprim-sulfamethoxazole 6 days before or during methotrexate therapy~* No concurrent participation in another clinical trial

- Gender: ALL
- Minimum Age: None
- Maximum Age: 21 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).